About DailyRounds
DailyRounds is a Healthcare company based in Bengaluru (India) founded in 2014, and was acquired by M3 in April 2019. Provider of a social platform for healthcare professionals. It operates in the Healthcare and Media & Entertainment sectors. DailyRounds has raised $1.7 million across 2 funding rounds from investors including Accel, Kae Capital and m3.com. The company has 282 employees. Its chief executive, as recorded, is Vineet Bagri. Its website dailyrounds.org draws about 131 thousand monthly visits. Its Indian entity Neuroglia Health Private Limited reported revenue of ₹773 Cr. DailyRounds offers products and services including Marrow, Creator+, India Drug Index, and Glia Circle. Its focus areas include Consumer, Social Platforms, Professionals and Doctors.
Company details
DailyRounds was founded in 2014 in Bengaluru, India, as a provider in the healthcare technology sector. A platform is operated where clinicians can share and discuss clinical cases, exchange knowledge, and access updates on journal articles, drug databases, ECG interpretations, treatment guidelines, and Continuing Medical Education courses. Operations focus on facilitating professional collaboration within the medical community.
- Headquarters Bengaluru, India
- Employees 282
- Stage Acquired
- SectorsHealthcareMedia & Entertainment
- Email••••••••
- Phone•••• ••••
- Website dailyrounds.org
- Social LinkedIn X Facebook Instagram
- Acquired by M3 (Apr 2019)
- Legal Name Neuroglia Health Pvt Limited
- Date of Incorporation 28 Apr, 2015
- Jurisdiction Bangalore, Karnataka, India
Associated legal entities of DailyRounds
DailyRounds operates through Neuroglia Health Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neuroglia Health Private Limited CIN U85110KA2015FTC079978 | Active | 28 Apr 2015 | Bangalore, Karnataka | ₹773 Cr | 282 | 3 | View details |
Products & Services of DailyRounds
DailyRounds offers a comprehensive portfolio of products and services, including Marrow, Creator+, India Drug Index, and Glia Circle.
Platform for medical students' exam preparation and performance analytics.
Tool for generating customized question papers for medical colleges.
Database providing comprehensive drug details for clinicians and practitioners.
Network offering discounts and wellness resources for medical professionals.
Apps and channels of DailyRounds
DailyRounds publishes 1 mobile app with over 500K+ downloads.
Funding Insights of DailyRounds
DailyRounds has successfully raised a total of $1.7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.2 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.7M
- Total Rounds 2
- Last Round Series A — $1.2M
- First Round $500,000
(Mar 2015)
- Investors Count 6
All 2 funding rounds of DailyRounds with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $1.2M | Series A | – | Accel | |
| Mar 2015 | $500,000 | Seed | – | GSF, Kae Capital | – |
7 investors in total: 7 institutional.
Investors in DailyRounds
DailyRounds has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Accel, Kae Capital and m3.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Accel is recognized as a leading venture capital firm. | 1983 | accel.com | Palo Alto, United States | |
Early-stage venture capital fund | beenext.com | Singapore, Singapore | ||
Venture capital firm focused on early-stage investments | powerhouseventures.com | Singapore, Singapore | ||
Early-stage tech investments are focused on by GSF in India. | gsfindia.com | Delhi, India | ||
Early-stage investing in tech startups in India. | 2011 | kae-capital.com | Mumbai, India | |
AXA Holdings Japan is engaged in providing insurance solutions. | axa-holdings.co.jp | Japan | ||
Japan's members-only networking site for healthcare professionals is operated. | 2000 | m3.com | Tokyo, Japan |
Investor details for DailyRounds
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Neuroglia Health Private Limited (DailyRounds)
Neuroglia Health Private Limited is the primary company behind DailyRounds. The board of Neuroglia Health Private Limited currently have 3 directors; the longest-serving is Kazutaka Kanairo, appointed in 2019. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kazutaka Kanairo DIN 07568887 | Director | 04 Mar 2019 | 7 yrs 7 mo | Neuroglia Health Private Limited |
| Eiji Tsuchiya DIN 07568886 | Nominee Director | 30 Jun 2020 | 6 yrs 4 mo | Neuroglia Health Private Limited |
| Vineet Bagri DIN 07613132 | Director | 24 Mar 2023 | 3 yrs 7 mo | Neuroglia Health Private Limited |
People of DailyRounds
1 people are tracked at DailyRounds (1 in leadership); the tracked headcount is 282.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for DailyRounds
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of DailyRounds
Figures of Neuroglia Health Private Limited, the primary company behind DailyRounds, for FY 2025. Revenue was ₹773 Cr (+18% year on year). Net profit was ₹363 Cr (47% margin). EBITDA was ₹369 Cr (48% margin).
- ₹773 CrRevenue · FY 2025 · +18% YoY
- ₹363 CrNet profit · 47% margin
- ₹369 CrEBITDA · 48% margin
- ₹1 LakhPaid-up capital
- 282Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Neuroglia Health Private Limited are on its company page.
Detailed financial statements for DailyRounds
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of DailyRounds
4 dated milestones of DailyRounds across 5 years, from founding to its latest funding, stage changes and deals.
- Founded DailyRounds is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series A, of $1.2M.
- Exit Acquired by M3.
Web traffic of DailyRounds
The website of DailyRounds (dailyrounds.org) receives about 130.6K visits a month.
- Monthly visits130.6K
▲ 61.6% vs previous month
Websites whose visitors overlap most with DailyRounds. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| needstreet.com | 100% | View details | |||
| carecloud.com | 97% | 59.2K | #640,915 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dailyrounds
Complete news archive for DailyRounds
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DailyRounds
DailyRounds was founded in 2014 and raised its 1st funding round 1 year after it was founded.
DailyRounds is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Vineet Bagri is the CEO of DailyRounds, as recorded in our data.
DailyRounds is a funded company, having raised a total of $1.7M across 2 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Mar 2015.
DailyRounds has 282 employees.
The primary company behind DailyRounds, Neuroglia Health Private Limited, reported revenue of ₹773 Cr for FY 2025, up 18% year on year.
DailyRounds was founded in 2014 in Bengaluru, India, as a provider in the healthcare technology sector. A platform is operated where clinicians can share and discuss clinical cases, exchange knowledge, and access updates on journal articles, drug databases, ECG interpretations, treatment guidelines, and Continuing Medical Education courses. Operations focus on facilitating professional collaboration within the medical community.
DailyRounds offers Marrow, Creator+, India Drug Index, and Glia Circle.
DailyRounds has 7 investors. Key investors include Accel, Kae Capital, m3.com, Beenext, and Powerhouse Ventures.
DailyRounds operates through Neuroglia Health Private Limited.
Yes. DailyRounds was acquired by M3 in April 2019.
The legal entities of DailyRounds currently have 3 directors, including Eiji Tsuchiya, Kazutaka Kanairo, Vineet Bagri.